Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To BlindnessInvestors Business Daily • 07/03/24
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: AnalystBenzinga • 07/03/24
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, EisaiInvestors Business Daily • 07/02/24
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's DiseasePRNewsWire • 07/02/24
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.The Motley Fool • 07/01/24